The spatial organization of Descemet's membrane-associated type IV collagen in the avian cornea by unknown
The Spatial Organization of Descemet's Membrane-associated 
Type IV Collagen in the Avian Cornea 
John M. Fitch,* David E. Birk,* Cathy Linsenmayer,* and Thomas E  Linsenmayer* 
*  Department  of  Anatomy  and Cellular Biology,  Tufts  University  School  of  Medicine,  Boston, Massachusetts  02111; and ~  Department 
of  Pathology,  University  of  Medicine  and Dentistry  of  New Jersey-Robert  Wood  Johnson  Medical  School, Piscataway,  New Jersey  08854 
Abstract.  The organization of type IV collagen in the 
unconventional basement membrane of the corneal en- 
dothelium (Descemet's membrane) was investigated in 
developing chicken embryos using anti-collagen 
mAbs. Both immunofluorescence histochemistry and 
immunoelectron microscopy were performed. In ma- 
ture embryos (>15 d of development), the type IV col- 
lagen of Descemet's membrane was present as an array 
of discrete aggregates of amorphous material at the in- 
terface between Descemet's membrane and the poste- 
rior corneal stroma. Immunoreactivity for type IV col- 
lagen was also observed in the posterior corneal 
stroma as irregular plaques of material with a mor- 
phology similar to that of the Descemet's membrane- 
associated aggregates. This arrangement of Descemet's 
membrane-associated type IV collagen developed from 
a subendothelial mat of type IV collagen-containing 
material. This mat, in which type IV collagen-specific 
immunoreactivity was always discontinuous, first ap- 
peared at the time a confluent endothelium was estab- 
lished, well before the onset of Descemet's membrane 
formation. 
Immunoelectron microscopy ofmature corneas re- 
vealed that the characteristic nodal matrix of Desce- 
met's membrane itself was unreactive for type IV col- 
lagen, but was penetrated at intervals by projections of 
type IV collagen-containing material. These projec- 
tions frequently appeared to contact cell processes 
from the underlying corneal endothelium. This spatial 
arrangement of type IV collagen suggests  that it serves 
to suture the corneal endothelium/Descemet's mem- 
brane to the dense interfacial matrix of the posterior 
stroma. 
PITHELIA are separated from stromal connective tis- 
sues by basement  membranes,  which are sheets of 
extracellular  matrix whose components are derived 
largely from the epithelial cells themselves. The molecular 
components of these matrices typically include a variety of 
glycoproteins (e.g., laminin, entactin), heparan sulfate pro- 
teoglyean, and type IV (~asement membrane  ~) collagen (see 
references  18, 29, 55 for reviews). Whereas most of these 
components are found in basement membranes throughout 
an organism, components with a more restricted tissue dis- 
tribution  (e.g.,  references  33,  53)  have  been  described. 
Moreover, regional diversity in the content or assembly of 
a variety of undefined antigens (e.g., 8, 20) and even of the 
"ubiquitous" molecular components of  basement membranes 
(10, 21, 30, 50) have been observed.  In the electron micro- 
scope, basement membranes typically appear as thin (~50- 
100 rim) amorphous sheets of electron-dense lamina densa 
sandwiched between two thin electron lucent zones (lamina 
lucida interna and externa; see references 18, 29, 60 for re- 
views). But variations on this theme also exist. For example, 
in some basement membranes,  the external electron-lucent 
layer is essentially absent; in others (e.g., Reichert's mem- 
brane and the anterior lens capsule) the electron-dense layer 
is thickened and has a filamentous morphology. 
Among the more unique basement membranes is Desce- 
met's membrane  of the vertebrate  cornea.  This is a thick, 
dense, acellular matrix that separates the corneal endothe- 
lium from the overlying stroma. In sections viewed by EM, 
Descemet's  membrane  appears  as  a  hexagonal  array  of 
electron-dense "nodes" embedded in an amorphous ground 
substance (16, 17, 22, 43, 47). The internodal separation is 
•100  rim; the nodes appear to be connected by a network 
of  thin filaments. Unlike most basement membranes, Desce- 
met's membrane  progressively  increases  in thickness with 
age. A matrix with a similar structure can be deposited in 
vitro by isolated corneal endothelial cells (38, 48, 49). 
The  molecular  composition  of  Descemet's  membrane 
is controversial,  and may be unique among the basement 
membranes.  Biochemical  studies  on  isolated  Descemet's 
membrane and biosynthetic studies on cultured corneal en- 
dothelium  have identified  the  usual  basement  membrane 
components, such as type IV collagen and laminin (1, 14, 28, 
32), but many of  these investigations and others (e.g., 46, 57) 
have also  identified a  variety  of interstitial  collagens and 
other macromolecules normally associated wit~ stromal ma- 
trices. More recent studies have indicated that the major col- 
lagen of Descemet's membrane  may be neither "basement 
membrane" nor interstitial,  but endothelial collagen (EC),I 
now termed type VIII (1, 2, 23, 24, 32). Many of  the apparent 
1. Abbreviation  used in this paper:  EC, endothelial collagen. 
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expression by endothelial cells in vitro (25, 27), which may 
in turn mirror similar modulations observed in a variety of 
corneal endothelial pathologies (26,  61). 
Immunohistochemical observations  of corneal  sections 
with  antibodies  against  extracellular  matrix  components 
have also demonstrated an association of Descemet's mem- 
brane with interstitial collagens, type IV collagen, and sev- 
eral  other  basement  membrane-specific  macromolecules 
(15, 19, 31, 38, 48, 49, 51, 54, 59). Using a series of mAbs 
against chicken type IV collagen in immunofluorescence  his- 
tochemistry, we have observed discontinuous immunoreac- 
tivity in the region of Descemet's membrane of corneas from 
mature chicken embryos (9) that could be resolved as an ar- 
ray of fine dots (36). This report describes the spatial organi- 
zation of the Descemet's membrane-associated type IV col- 
lagen in mature corneas, its relationship to the nodal matrix 
of Descemet's membrane, and its appearance during devel- 
opment. 
Materials and Methods 
Tisslle 
White Leghorn chicken eggs were obtained from Spafas,  Inc.  (Norwich, 
CT) and incubated for 5-19 d at 380C. Unfixed anterior eyes used for im- 
munofluorescence  histochemistry were removed in HBSS, soaked in 7-8 % 
sucrose in PBS for 5-10 min, embedded in OCT (Miles Laboratories, Elk- 
hart, IN), and frozen in liquid nitrogen.  The blocks were stored at -20°C 
until used.  Some tissue was fixed lightly (2-4% paraformaldehyde  in PBS, 
2-5 rain) before being immersed in sucrose.  No differences were seen be- 
tween unfixed and lightly fixed material. 8 #m-thick frozen sections were 
mounted on 12-spot slides (Shandon Scientific Instruments, Sewickley, PA) 
coated with albumin or polylysine (tool wt '°250,000; Sigma Chemical Co., 
St.  Louis,  MO), dried for 2-4 h, and stored at -20°C. 
Other tissue was prepared for sectioning in an ultracryotome (Reichert 
FCA; Reichert, Vienna, Austria).  These corneas were fixed for 1 h with 2 % 
paraformaldehyde  containing periodate  and  lysine  in  phosphate buffer 
(PLP; see reference 42), or with 3.5%  paraformaldehyde  in PBS).  They 
were then rinsed in PBS and infused in a graded series of buffered sucrose 
solutions,  to 2.3 M sucrose,  in PBS. Wedges of corneal tissue were then 
frozen on stubs in liquid freon cooled to liquid nitrogen temperatures,  and 
stored in liquid nitrogen until used.  Thick (0.5-1 t~m) sections from these 
specimens,  for use in immunofluorescence  studies,  were mounted on 12- 
spot slides coated with Cell-Tak adhesive (Biopolymers,  Inc., Farmington, 
CT); 100-nm thin sections for use in immunoelectron microscopy (see be- 
low) were transferred to formvar-coated grids via a drop of 2.3 M sucrose, 
and stored at 4°C on 2% gelatin in PBS until used. 
Antibodies 
The production and characterization of type-specific mAbs against collagen 
types I (BAI, see 35), IV (IA8, see 9; IIBI2 and ID2, see 41), and X (AC9, 
see 52) have been described previously. In addition, another of our mAbs 
against chicken type I collagen (DIM) was frequently  used.  This antibody 
arose from the same fusion as did I-BAI, but recognizes  an epitope at the 
other end of the triple helical molecule (unpublished observations). All of 
the antibodies used in this study have been tested for cross-reactivity  to the 
other collagen  types and are collagen  type specific;  different  antibodies 
within each type-specific group recognize different epitopes on the triple he- 
lical molecule (see references cited above, and unpublished observations). 
All antibodies were stored at 40C. In the immunofluorescence  experi- 
ments described here, the antibodies were used in the form of either undi- 
luted  superuatant from spent hybridoma cultures or ascites fluid diluted 
1/300-1/500 with PBS. For coating gold colloidal particles for use in immu- 
noelectron microscopy  (see below), IgG was purified on a preparative pro- 
tein A column (Bio-Rad Laboratories, Richmond, CA) using the Affi-Prep 
reagents and protocol, and was dialyzed  into PBS and stored at 4°C until 
used. 
lmmunofluorescence Histochemistry 
The pattern of anticollagen immunoreactivity in 8-/zm frozen sections was 
revealed using an indirect immunofluorescence  procedure described previ- 
ously (9). Sections of unfixed material were blocked with 0.1% BSA in PBS 
for 10-20 rain and then covered with a drop of the primary antibody for 
1-4 h at room temperature (RT) or overnight at 4°C. Sections of lightly fixed 
(2-4 % paraformaldehyde  in PBS, 5-10 rain) tissue were quenched for 30-60 
rain with 0.14 M Tris buffer containing 0.8% BSA and 0.12 M glycine, pH 
7.0, before their exposure  to the primary antibodies.  The slides were then 
washed thoroughly with PBS and incubated with a rhodamine-conjugated 
goat anti-mouse IgG  second antibody (1  h,  RT),  washed  in PBS,  and 
mounted in glycerol/PBS  (95:5). Essentially the same procedure was used 
to label 0.5-1-t~m frozen sections for observation by immunofluorescence, 
except that the sections  were quenched with PBS containing glycine  (50 
mM) and lysine (50 raM) and then 10% FCS in PBS. 
In most experiments,  several different mAbs against each collagen type 
were used, along with a mixture of all of the antibodies in each collagen 
type-specific group.  The type IV collagen-specific  mixture in particular 
gave an enhanced immunofluorescent  signal, but without any change in the 
pattern of immunoreactivity in the posterior corneal region.  Background 
immunofluorescence  was assessed  by the use, as a negative control, of the 
antibody against type X collagen (AC9), which is specific for hypertrophic 
cartilage. 
To enhance further the intensity  of the fluorescent  signal, many of the 
sections  received two rounds of reaction with the primary and secondary 
antibodies (36).  In this procedure,  45-rain incubations with primary and 
secondary antibodies were used in the second round. 
In some experiments,  the tissue sections were first pretreated with dilute 
acetic acid (0.2M HAc, 20 min, RT), or testicnlar hyaluronidase (type IV-S, 
Sigma Chemical Co.; 1 mg/ml, in PBS, 30 rain, 37°C) before the applica- 
tion of the primary antibody. The first procedure has been shown to expose 
epitopes masked by their fibrillar organization  (34); the second, by matrix 
glycosoaminoglyeans  (58). We also used mixed glycosidases (Miles Labo- 
ratories, 5-10 mg/ml, 0.1 M PO4, pH 5.5, 15-30 rain, 37"C) or elastase 
(Sigma Chemical Co., type II,  15-75 U/ml, 0.1 M PO4, pH 8.2,  15 rain, 
37°C) as unmasking reagents.  In other experiments,  potential masking by 
fibrillar organization  was tested in another way by using corneal sections 
from embryos made iathyritic by the administration of/3-aminopropionitrile 
during development,  using a procedure described previously  (11). Finally, 
sections digested with vertebrate interstitial collagenase (kindly provided by 
Dr. Karen Hasty and Dr. Carlo Maiuardi, University of Tennessee School 
of Medicine, Memphis, TN) for 12--48 h as described previously  (12) were 
examined for unmasking of type IV collagen by other collagen types suscep- 
tible to this protease. 
lmmunoelectron Microscopy 
Both preembedding immunoelectron microscopy  with 8 ttm cryosections 
and postembedding immunoelectron microscopy with 100 nm ultracryosec- 
tions, using monoclonal antibodies indirectly labeled with colloidal gold as 
well  as  directly-conjugated  antibody-colloidal  gold probes (see  below), 
were performed. The procedure for preembedding immunoelectron micros- 
copy was as described previously (12). In brief, unfixed or lightly fixed thick 
(8 #m) cryosections were quenched BSA in Tris/glycine buffer, reacted with 
antibody-gold complexes, and washed extensively. In some experiments,  the 
sections were incubated with vertebrate collagenase,  as described (12), for 
12-48 h before application of the antibodies.  They were then fixed with 4% 
paraformaldchyde  and 2.5% glutaraldehyde  and postfixed with 1.25% os- 
mium tetroxide,  dehydrated,  and embedded in an Epon-araldite  mixture. 
Blocks were removed from the surface  of glass slides,  sectioned,  and ob- 
served with a Phillips CM-10 transmission electron microscope. 
Postembedding  immuncelectron microscopy  on thin ultracryosections 
was performed using immunogold  complexes  in both directly  labeled as 
well as indirectly  labeled procedures.  For direct labeling of epitopes,  thin 
ultracryosections  on formvar-coated  grids were first quenched in PBS con- 
taining glycine (50 raM) and lysine (50 raM) followed by 10% FCS in PBS. 
They were then immersed in dilution fluid (PBS containing 1% BSA,  1% 
gelatin, 0.1% Tween,  0.1% Triton X-100) before being incubated in anti- 
body-gold complexes  (diluted  in dilution fluid) for 1-6 h (usually  5-6 h) 
at RT. The sections were immersed for 30 min in six changes of washing 
solution (PBS containing 0.1% Tween, 0.1% Triton), and then four times 
in H20. They were then contrasted and protected following the method of 
Tokayasu (56) by immersion in 0.15 M oxalic acid containing 2% uranyl 
acetate, pH 7, washing with water, and infusion with 1% methyl cellulose 
(25 cps, Sigma Chemical Co.) containing 0.2% uranyl acetate.  Dried grids 
The Journal of Cell Biology, Volume 110, 1990  1458 l~gure L  Thick (8 am) frozen sections of anterior eyes from 19-20-d chicken embryos reacted with mAbs for type IV (A, B, and D) or 
type X (C) collagen. Bar, (A) 100 am; (B-D) 25/zm. In the cornea, immunoreactivity  for type IV collagen is associated with the basement 
membranes  of the corneal epithelium (,4, small arrows) and endothelium  (Descemet's membrane;/arge  arrows in A), and in corneal nerves 
(A, arrowhead) within the corneal stroma (cs). In the posterior stroma (towards the endothelial surface), scattered plaques of immunoreac- 
tivity can be seen (faint specks in A; more prominent flecks in B and D). Elsewhere, type IV collagen-specific immunoreactivity  is found 
in the basement membranes of the striated muscle and blood vessels of the iris (i) and in the thick lens capsule surrounding the lens (l). 
In the posterior cornea viewed at higher magnification (B), Descemet's membrane-associated immunoreactivity  for type IV collagen can 
be resolved as a compact array (arrows) of fine punctate fluorescence ('dots").  Coarser flecks of immunofluorescence  (e.g., arrowheads) 
in the overlying stroma (s) are also observed. These structures do not react with an irrelewant antibody against type X collagen (C). In 
corneas sectioned tangentially, approximately  parallel to the endothelial surface, and reacted for type IV collagen (D), the array of dots 
is generally wider and more irregular,  but the punctate pattern of immunofluorescence within this array is maintained. 
were observed and photographed with a Philips CM-IO transmission  elec- 
tron microscope. 
In the indirect  labeling  procedure, thin ultracryosections  were quenched, 
labeled with primary  mAb, diluted  in dilution  fluid, for 1-3 h, RT, and then 
washed for 20 rain in four changes of washing solution  and once in dilution 
fluid. Bound  antibody  was then labeled for 3--4 h with either l0 or 15 rim 
colloidal gold particles  coated with goat anti-mouse  IgG (Janssen  Pharma- 
ceuticals, Piscataway, NJ) diluted 1:20 with dilution fluid. The sections 
Fitch et al. Descemet's  Membrane-associated Type IV Collagen  1459 Figure 2. Topography  of  the endothelial surface of  thick (8 #m) cor- 
neal sections at loci with a punetate pattern of immunofluorescence 
versus a linear pattern of immunofluoreseence  for type IV collagen. 
Bar (A), 10 ttm. A shows the posterior region of a transverse section 
of a cornea containing adjacent regions with linear and punctate 
patterns of immanottuorescence. If this section were embedded in 
plastic, removed from  the glass slide, and then sectioned perpendic- 
ular to the endothelial surface (as was the case for the sections in 
Fig. 4), thin sections through the linear (e.g., b) versus punctate 
(e.g., c) regions would appear as diagrammed in B and C. The re- 
gion showing a linear pattern of fluorescence (B) would show an 
erect orientation of the endothelium (arrowhead) and Descemet's 
membrane. Sections through the region containing an array of  dots 
(C)  would show an  endothelium  (arrowhead) and  Descemet's 
membrane that has "toppled" to varying extents. Thus, for thick 
(8 #m) frozen sections of corneas reacted for type IV collagen, in 
regions where the posterior surface of the cornea has toppled, one 
is viewing the pattern of type IV collagen-specific immunofluores- 
cence essentially en face (horizontal to the endothelial surface), 
showing a discontinuous array of  punctate immunofluorescence; in 
untoppled (erec0 regions, the array is viewed edge-on, with the su- 
perimposed fluorescent dots giving an apparently continuous linear 
pattern of immunofluorescence, s, stroma. 
were then rinsed for 30 min with washing solution (six changes) and pro- 
cessed as described above. 
In some experiments, we attempted to expose potentiaUy masked epi- 
topes by treating the sections with enzymes (mixed glycosidases [Miles, 
7  mg/ml in 20 mM Tris, 60 mM NaCl,  2  mM CaCI2,  pH 6.8, 15 rain, 
37°C],  or testicular hyaluronidase [Sigma Chemical Co.,  IV-S,  0.1%  in 
PBS, pH 7.3], and/or heparitinase [ICN Radiochemicals, 50 units/ml, in 50 
mM  Tris,  150  mM  NaCl,  5  mM CaCI2,  pH  6.8])  at  37°C  for 20-30 
rain/enzyme, or with 4  M  guanidine (in 50 mM Tris, pH 7) for 5 min at 
RT. The unmasking procedure was performed after the quenching steps de- 
scribed above, and was followed by two to three rinses in PBS or Tris buffer 
and then dilution fluid before labeling with the antibody-gold complexes. 
Preparation of  Colloidal Gold-Antibody Complexes 
Colloidal gold particles with diameters of 5 or 15 tun were obtained from 
Janssen Pharmaceuticals. They were coated with affinity-purified mono- 
clonal IgG preparations in 2 mM borate buffer at pH 8.5-9, following a pro- 
cedure essentially as described previously (3), with minor modifications 
from the Janssen protocol. 
Antibody-gold complexes were centrifuged through a  10-35 % glycerol 
gradient in 20 mM Tris, 150 mM NaCI, pH 8.2, with 1% BSA, as described 
(3); material from the middle of  the gradient was removed and diluted with 
1% BSA in Tris/NaCI buffer to give an absorbance at 510 nm of 2.5 (5-nm 
particles) or 3.5 (15-nm particles). These stocks were stored at 4°C until 
used. For use in single- or double-label experiments  on thin frozen sections, 
the antibody-gold  particle stocks were diluted with dilution fluid (see above) 
to  1:12-1:15 (Asl0  =  0.2-0.3) for each antibody. 
Results 
Our observations on the arrangement of endothelial type IV 
collagen in  "mature" corneas  (>15  d  of development),  in 
which a  substantial nodal Descemet's membrane matrix is 
present, are presented first. These are then followed by our 
immunofluorescence histochemical findings on the develop- 
ment of  this complex at stages before and including the onset 
of Descemet's membrane deposition. 
Immunofluorescence Histochemistry 
In 8-#m frozen sections of i7-20-d anterior eyes reacted with 
antibodies against type IV collagen, linear type IV collagen- 
specific immunofluorescence was seen associated with base- 
merit membranes of blood vessels, muscle, the lens (Fig.  1 
A),  and the corneal epithelium (Fig.  1 A, small arrows),  2 
and nerves (arrowhead, Fig. 1 A). In the posterior region of 
the cornea, however, we observed immunoreactivity for type 
IV collagen as an array of fine punctate fluorescence (which 
we term "dots  ~) in the region of Deseemet's membrane (/arge 
arrows, Fig. i, A and B); measurements in photographic en- 
largements gave an interdot separation of ~,1 #m. This punc- 
tate  pattern  of type IV  collagen-specific immunofluores- 
cence was observed in no other basement membranes (e.g., 
those of blood vessels, muscle, nerve, lens), whether these 
structures were sectioned transversely or tangentially (not 
shown). In the o~,erlying stroma, we also saw occasional ir- 
regular flecks of  coarse immunoreactivity (e.g., arrowheads, 
Fig. 1 B). None of these structures reacted with an antibody 
against type X collagen (Fig.  1 C). 
Attempts to expose potentially masked epitopes by react- 
ing sections of corneas from lathyritic chicken embryos with 
antibodies at low temperatures, or by treating sections with 
dilute acetic acid, testieular hyaluronidase, mixed glycosi- 
dases,  vertebrate coUagenase, elastase, or 4  M  guanidine, 
before application of  the primary antibody did not change the 
punctate pattern of immunoreactivity for type IV collagen 
(not shown). 
A variety of  observations indicate that, in such 8-gin-thick 
cryosections, the array of fine Descemet's membrane-asso- 
ciated dots reflects the distribution of type IV collagen in the 
2. We have previously reported (9) that little, if any immunoreactivity for 
type IV collagen could be detected in the corneal epithelial basement mem- 
brane using our mAbs. We now find that, in most cases, this basement mem- 
brane reacts with these antibodies, albeit weakly when compared with other 
basement membranes; on occasion, however, we continue to encounter ex- 
amples where the epithelial basement membrane fails to react for type IV 
collagen. At present, we have no explanation for this inconsistent result. 
The Journal of Cell Biology,  Volume 110, 1990  1460 Figure 3. Semithin (0.5-1/~m) transverse frozen section of a cornea from an 18-d chicken embryo, reacted for two rounds with a mixture 
of three mAbs against type IV collagen. Bar, 10 pro. In the posterior cornea, the pattern of subendothelial immunoreactivity (e.g., arrows) 
is discontinuous. The length of the arrows approximates the width of the underlying corneal endothelium, s, stroma. (lnset) Epithelial 
basement membrane (arrowheads) from the same section, showing a pattern of continuous linear inununofluorescence, epi, epithelium. 
Figure 4.  Preembedding immunoelectron microscopy of 15-d corneal thick (8 gm) frozen sections labeled with colloidal gold particles 
coated with type IV collagen-specific antibodies, and then embedded and sectioned for EM. Bars, 250 nm. Bound 5-nm gold particles 
were observed mostly in small discrete clusters (arrows)  at the interface between Descemet's membrane (asterisk) and the corneal stroma 
(s), and in irregular plaques (arrowheads and inset) of amorphous material within the stroma itself. The matrix of Descemet's membrane 
is unlabeled. 
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the stage of development shown in Fig. 1, Descemet's mem- 
brane is no more than 1/~m in thickness (22), and in some 
sections, short stretches of the Descemet's membrane-asso- 
ciated  type IV  collagen-specific immunofluorescence as- 
sumed a continuous linear pattern consistent with this size 
(Fig. 2 A). However, in most transverse sections, the array 
of dots was much wider, varying from <3 to 12/~m, and in 
corneas sectioned tangentially (i.e., parallel to the endothe- 
lial surface), this array was even wider and more irregular 
than in transverse sections (Fig. 1 D). Nevertheless, the ap- 
pearance of the dots in both tangential and transverse sec- 
tions  was  identical.  Together these  observations  indicate 
that, in transverse 8-/zm frozen sections, Descemet's mem- 
brane and its endothelium has largely toppled over to varying 
extents, thus allowing the posterior region of the cornea to 
be viewed en face (diagrammed in Fig. 2). This interpreta- 
tion was bolstered by observations of semithin (0.5-1  #m) 
frozen sections of 18 day corneas reacted for type IV colla- 
gen, which gave patterns of immunofluorescence resembling 
a broken line or a string of beads (Fig. 3); by comparison 
immunofluorescence in the epithelial basement membrane 
appeared as a thin continuous line (inset, Fig. 3). While use- 
ful  in  elucidating the  spatial  organization of the array of 
Descemet's-related dots, the semithin cryostat sections still 
did not allow us to determine whether the Descemet's mem- 
brane-associated  type  IV  collagen  was  present  within 
Descemet's membrane itself. 
Immunoelectron Microscopy 
To localize precisely type IV collagen in the posterior cor- 
nea,  we performed preembedding and postembedding im- 
munoelectron microscopy using colloidal gold particles as 
electron-dense markers.  The preembedding procedure re- 
vealed gold-labeled type IV collagen distributed along the 
interface between  Descemet's membrane and the corneal 
stroma (Fig. 4) and in irregular plaques in the stroma itself 
(Fig. 4, inset). The gold particles in the Descemet's mem- 
brane-stroma interface were distributed largely in clusters 
(arrows, Fig. 4), which likely correspond to the Descemet's 
membrane-associated "dots" of  type IV collagen-specific im- 
munofluorescence described above. Between the clusters of 
immunoreactivity,  label  for type  IV  collagen  was  either 
sparse or absent. This pattern of type IV collagen-specific 
immunoreactivity was observed also in corneas made lathy- 
ritic by application of/~-aminopropionitrile during develop- 
ment, and in sections digested with vertebrate collagenase 
(not shown), which will degrade most interstitial collagens 
but not type IV. In all cases, Descemet's membrane itself was 
not labeled, but it is possible that in these preparations this 
dense matrix was not penetrated by the applied antibodies. 
To obviate the penetration problem, immunolabeling of  ul- 
trathin frozen sections was  used.  Corneas  from  18-d-old 
chicken embryos were embedded in 2.3 M sucrose, frozen, 
and thin sections ('~100 nm) were labeled with the antibod- 
ies, using both indirect and direct procedures that used col- 
loidal gold particles as electron-dense markers. Both proce- 
dures  yielded the  same  results.  In  some  experiments,  a 
double-label  antibody  mixture  was  used  that  included 
anti-type IV  collagen antibody coupled to one size gold 
along with another antibody on a different-sized gold that 
served either as a negative control (anti-type X collagen) or 
a positive control (anti-type I or VI collagen) for stromal 
collagens.  3 Again, type IV collagen-specific gold particles 
were distributed in the interfacial matrix, mostly in small 
(0.5/~m or less) clusters (Fig. 5, A, C, and D), and in stromal 
plaques  (Fig.  7).  In these preparations,  however, we ob- 
served in addition that the type IV collagen-containing ag- 
gregates at the interface in many cases penetrated the under- 
lying Descemet's membrane, and in some cases extended all 
the way to the endothelial surface (Fig. 5, A and C; Fig. 6). 
We also frequently found such aggregates to be associated 
with discrete endothelial cell processes projecting upward 
into Descemet's membrane (Fig. 5, A and C; Fig. 6). Occa- 
sionaUy a cluster of type IV collagen-specific immunogold 
was observed that appeared to be entirely embedded within 
the nodal matrix of Descemet's membrane (e.g., arrowhead, 
Fig. 5 F). We interpret such a profile as probably represent- 
ing an obliquely sectioned finger of penetrating material whose 
stromal and endothelial continuities were not included in the 
section. Likewise, clusters of immunoreactivity confined to 
the stroma-Descemet's membrane interface (e.g., Fig. 5 D) 
may represent grazing sections of units of penetrating type 
IV  collagen-containing material.  The characteristic nodal 
matrix of Descemet's membrane itself was not labeled by the 
type IV collagen-specific antibodies,  nor by antibodies against 
collagen types I or VI (not shown), or X (Fig. 5, B and G; 
Fig. 6). 
Attempts to expose potentially masked epitopes by pre- 
3. Each experiment  included reciprocal  combinations  of double-label mix- 
tures (e.g., IV5 + Xi5 and IVy5 + Xs). The results obtained  for each  com- 
bination did not differ,  but for each antibody  the level of labeling achieved 
by the 15-nm  complex  was about  three-  to fivefold  lower  than that observed 
for the corresponding  5-nm complex. 
Figure 5. Postembedding immunoelectron microscopy of thin (,,o100 nm) frozen sections of 18-d embryonic chicken corneas labeled for 
collagen type IV (A, C-F) or type X (B and G) after incubation with elastase (E-G) or buffer (A-D). Descemet's membrane-associated 
immunoreactivity. Bars, 0.5/zm. (Bar A is also applicable to B and E-G; bar C is also applicable to D.) In sections incubated with buffer 
alone (A-D), type IV collagen-specific antibodies, identified by 15-nm gold particles coated with a second antibody, are found largely 
at the interface between Descemet's membrane (asterisk in A) and the stroma (s), in a pattern of  discrete clusters (arrows)  of immunoreactiv- 
ity. Some of  these type IV collagen-containing structures appear to penetrate the nodal matrix of Descemet's membrane, but the Descemet's 
membrane matrix itself is negative. After digestion with elastase (E-G), the endothelium becomes generally separated from Descemet's 
membrane, leaving hollow depressions in the matrix where cell processes have pulled away (curved  arrows). But the characteristic morphol- 
ogy of the Descemet's membrane matrix appears similar to that of controls. In such preparations, a noticeably higher level of labeling 
for type IV collagen is achieved, but the general pattern of discontinuous immunoreactivity (arrows) is still clearly evident, and the nodal 
Descemet's membrane matrix remains negative for type IV collagen. The binding of antibody against type X collagen is negligible in both 
control (B) and digested (G) sections, s, stroma; e, endothelium. 
Fitch et al. Descemet's  Membrane-associated Type IV Collagen  1463 Figure 6.  Structure of penetrating aggregates of type IV colla- 
gen-containing material in thin (,~100 ran) frozen sections of 18-d 
corneas double-labeled with colloidal gold particles coated with an- 
tibodies against collagen type IV (5 nm) or type X (15 nm). Bars, 
250 tun. A and B show two aggregates (arrows) of  material contain- 
ing type IV collagen that appear to extend all the way to the surface 
of the endothelium. The gold particles are associated with moder- 
ately electron-dense amorphous  material  with very little linear 
(filamentous) structure. However,  in some loci (B) where the pene- 
trating matrix material appears to meet the apical tip of an endothe- 
lial cell process, thin (<5 nm) filaments (arrowheads) are observed. 
treatments with 4 M guanidine, mixed glycosidases, or tes- 
ticnlar  hyaluronidase  and/or  heparitinase  before reaction 
with the antibodies did not reveal any noticeable additional 
immunoreactivity for type IV collagen (or type I or VI) in 
Descemet's membrane. However, digestion with elastase be- 
fore application of the antibodies did appear to allow more 
anti-type IV collagen antibody to be specifically bound (Fig. 
5,  and  unpublished  observations).  Nevertheless,  even  in 
these preparations,  the nodal matrix of Descemet's mem- 
brane continued to be unreactive for type IV collagen. 
The fine structure of the type IV collagen-containing ma- 
terial in the posterior cornea consisted of some thifi (<5 nm) 
filaments embedded in an amorphous matrix (Figs. 6 and 7). 
The interface between Descemet's membrane and the cor- 
neal stroma was generally more electron-dense than the sur- 
rounding stromal and Descemet's membrane matrices, but 
did  not possess  a  discrete,  recognizable basement  mem- 
brane. The small clusters of Descemet's membrane-associ- 
ated type IV collagen-containing material and  the larger 
stromal plaques (Fig. 4; Fig. 7) had a similar morphology, 
although filaments were more readily observed in the stro- 
mal plaques (compare Figs. 6 and 7). In Descemet's mem- 
brane-associated  material,  fine filaments were seen most 
frequently where the penetrating fingers approached the api- 
cal tips of endothelial cell processes (Fig. 6 B). 
Development 
The avian cornea develops in a series of well-defined stages 
involving the deposition of two stromal  matrices and  the 
differentiation of its endothelial and stromal cell populations 
from  precursors in the surrounding mesenchyme (see refer- 
ences 16 and 17 for reviews). The corneal endothelium arises 
from periocular mesenchymal cells that migrate centripe- 
tally between the acellular primary stroma and the underly- 
ing lens capsule beginning at ~4 d  of development (stage 
22). These cells form a continuous endothelium by 5 d (stage 
26). Soon afterwards (stage 27), the primary stroma swells 
and is invaded by another wave of mesenchymal cells which 
then secrete a secondary corneal stroma. Deposition of the 
characteristic nodal matrix of Descemet's membrane by the 
endothelium begins at ~,,9 d of development, and continues 
into adulthood. 
In frozen sections of eyes from stage 22-24 embryos, the 
migrating presumptive endothelial cells had little, if any, im- 
munofluorescence for type IV collagen associated with them 
(data not shown). At stage 25/26, however, when the forma- 
tion of an intact endothelium is under way, these cells were 
decorated  with  scattered,  discontinuous  immunofluores- 
cence for type IV collagen (e.g., small arrows, Fig.  8 A). 
Most of this appeared to be localized on their basal surfaces, 
adjacent to the acellnlar primary stroma.  Sections reacted 
for type X collagen (negative control, Fig. 8 B) showed only 
nonspecific binding to the corneal epithelium. This immu- 
noreactivity rapidly increased in density, forming a  loose 
network of  fine type IV collagen-containing strands (arrows, 
Fig. 8, C and D).4 This network, which we term the ~suben- 
dothelial mat," remained intact as  the corneal stroma ex- 
panded greatly (Fig. 8 D), suggesting its anchorage to the en- 
dothelial surface. With time, immunoreactivity for type IV 
collagen continued to increase in density at this site, so that 
by the time that the nodal matrix of Descemet's membrane 
first becomes detectable (9 d of development), it has assumed 
the appearance of  a finely woven fabric, but with discontinni- 
4. At about this time, the primary  stroma swells and becomes  invaded  by 
periocular  mesenchymal  cells. These  events  also  correlate  with  the presence 
throughout the corneal stroma of numerous profiles  of type IV collagen- 
specific immunoreactivity  (Fig. 8, C-F). Some  of these structures, which 
are transitory, appear identical to the ~tromal flecks"  described earlier. 
Others, however,  differ  in their morphology,  immunoreactivity  with other 
antibodies, and, probably, origin (work in progress). 
The Journal of Cell Biology,  Volume 110, 1990  1464 Figure 7. Structure of stromal plaques of type IV collagen-containing  material in thin (~100 nm) frozen sections of 18-d corneas directly 
labeled with antibodies against collagen types IV and X or VI. Bars, 250 nm. A shows a section double-labeled with antibodies against 
collagen types IV (5 nm) and X (15 nm). A stromal plaque (arrows) containing type IV collagen is located  just above Descemet's membrane 
(asterisk), where diffuse interfacial  labeling for type IV collagen is found. Close examination  of  the plaque reveals  a filamentous  component 
(e.g., arrowhead) within the amorphous matrix. B shows  another stromal plaque in a section  double-labeled  with antibodies against  collagen 
types IV (15 nm) and VI (5 nm). The absence of 5-nm gold particles within the plaque suggests  that its filamentous component is unlikely 
to contain type VI collagen. 
ties, or "boles" (Fig. 8 E). With continued development (and 
ongoing deposition of the nodal matrix of Descemet's mem- 
brane) the associated type IV collagen-specific immunore- 
activity gradually lost its meshwork pattern, and assumed by 
11-12 d (Fig. 8 F) a more punctate pattern of  immunofluores- 
cence. This became more sharply defined in mature corneas 
(e.g., Fig.  1, B and D). 
Discussion 
Descemet's membrane is a specialized extracellular matrix 
that is structurally unique among the basement membranes, 
appearing as a hexagonal array of nodes and internodes (22). 
Our  observations  suggest that  this  nodal  matrix may be 
unique in its molecular composition as well: unlike most 
basement membranes,  it appears  not to  contain type IV 
(basement membrane) collagen. We did, however, find type 
IV  collagen intimately associated with Descemet's mem- 
brane, as a component of material that penetrates at regular 
intervals  the  characteristic  hexagonal  (nodal-internodal) 
matrix of this structure. But the Descemet's membrane ma- 
trix itself was consistently unreactive for type IV collagen. 
Our immunoelectron microscopic observations revealed 
binding of  anti-type IV collagen antibodies to large irregular 
plaques of amorphous/filamentous material in the posterior 
corneal stroma. These likely correspond to the coarse flecks 
of type IV collagen-specific immunoreactivity observed by 
immunofluorescence histochemistry. By morphological and 
developmental criteria, they appear quite similar to the tran- 
sitory "interstitial bodies" described in early embryos by Low 
(37) and others (7, 39, 41) and suggested to function in cell mi- 
gration (4, 40). The stromal plaques described here appear 
to differ from the "basement membrane-like plaques" (51) or 
the microfibril-associated type IV collagen (44)  observed 
throughout adult mouse corneal stromas, in that they lack a 
linear morphology, are transitory, and become confined to 
the posterior third of the cornea during development. 
The absence of immunoreactivity for type IV collagen in 
Descemet's membrane does not necessarily imply absence 
of the protein, so we cannot completely exclude the possibil- 
ity that it might be present in a masked form. It seems likely, 
however, that these results do in fact reflect the true distribu- 
tion of type IV collagen, at least in avian species. Our three 
mAbs against type IV collagen recognize epitopes located on 
separate domains of the molecule (9, 37). We consider it un- 
likely that in Descemet's membrane all of these epitopes are 
masked, and remain masked after treatment with acetic acid, 
/~-aminopropionitrile,  4  M  guanidine,  vertebrate  collage- 
nase, elastase, glycosidases, and glycosaminoglycan-degrad- 
ing enzymes. It is of interest that elastase digestion did ap- 
pear to increase binding of the antibodies to the interfacial 
matrix and its penetrating fingers. This suggests that the type 
IV collagen at this interface might be closely associated with 
microfibrils,  which  are  probably  enriched  in  Descemet's 
membrane-associated matrix  (45)  and  are  a  substrate  of 
elastase (5). 
Our  findings appear  to be compatible with recent bio- 
chemical analyses of isolated bovine and rabbit Descemet's 
membrane showing type IV collagen to be a minor compo- 
nent of the matrix, the major collagen being type VIH (2, 
23). Such preparations would undoubtedly include the pene- 
trating  domains of type IV  collagen-containing material 
along with the predominant nodal Descemet's membrane 
matrix. We also found that avian Descemet's membrane did 
Fitch et al, Descemet's Membrane-associated Type IV Collagen  1465 Figure 8.  Thick (8 pm) frozen sections  of anterior eyes from chicken embryos at various stages of development  reacted with antibodies 
against collagen type IV (A, C-F) or type X (B). Bar (A),  10/~m. A and B show eyes at stage 26 (5 d of development)  labeled  for type 
IV (A) or type X (B) collagen. The endothelial  cells, which have completely covered the posterior surface of the primary stroma (s), show 
discontinuous immunoreactivity for type IV collagen (e.g., small arrows), but not for type X (B). (Large arrows) Anterior lens capsule. 
By stage 28 (6 d, C), the endothelial-associated  immunoreactivity becomes organized into a loosely-woven mat (arrows)  of  type IV collagen- 
containing material.  The overlying stroma also contains abundant immunoreactivity for type IV collagen. At stage 30 (7 d, D), rapid stromal 
expansion  has dispersed somewhat the stromal  immunoreactivity for type IV collagen, but not that of the subendothelial  mat (arrows). 
The pattern of subendothelial  immunoreactivity becomes more dense with time, so that by 9 d (E), individual strands are difficult to resolve. 
With further maturation, a punctate pattern of immunofluorescence (F,  11  1/2 d) begins to emerge. 
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collagen types I  and VI (this report), nor with antibodies 
against collagen types II, III, and V (unpublished observa- 
tions).  Some of these antibodies react strongly, however, 
with the stroma and the dense interface between Descemet's 
membrane and the stroma. From other work on Descemet's 
membrane (2, 23), we surmise that the collagenous compo- 
nent of Descemet's membrane proper is largely, and perhaps 
exclusively, type VIII. It is possible that most of the intersti- 
tial collagens that have been identified in extracts of isolated 
Descemet's membrane may be derived from this tightly ad- 
herent interfacial matrix (see below). 
The results of this study appear to contradict some pub- 
lished immunohistochemical studies (15, 48) that have local- 
ized type IV collagen throughout the nodal matrix of Desce- 
met's membrane. We have no explanation for this, other than 
to cite differences in species, developmental age, and anti- 
bodies used. On the other hand, we consider the studies of 
others that have found by immunohistochemistry only faint 
or restricted immunoreactivity for type IV collagen in the re- 
gion of Descemet's membrane (13, 23, 49) to be compatible 
with our observations. 
Most of the Descemet's membrane-associated type IV col- 
lagen is present in the interfacial region in aggregates that 
frequently appear to penetrate the Descemet's membrane 
matrix and, at least in some cases, extend to the endothelial 
surface; lesser amounts are distributed diffusely along this 
interface. The fingers of penetrating type IV collagen-con- 
taining  material  may  correspond to  the  domains  of fine 
filamentous ("cloud-like") material observed by Jakus (22) in 
thin sections of Descemet's membrane. The association of 
these aggregates  of type IV  collagen-containing material 
with endothelial cell processes suggests an attachment to 
those processes. It is noteworthy that the projection of these 
processes into Descemet's membrane creates dimples in the 
posterior surface of Descemet's membrane that are similar 
to those described recently in the developing rabbit cornea (6). 
These observations indicate that one role of the type IV 
collagen in this region may be to suture the endothelium and 
its basement membrane to the overlying stroma, via the ex- 
tremely dense network of  fibrils and filaments that comprises 
the interfacial matrix. The intimate intermingling of stromal 
and basement membrane elements at this interface seems to 
enhance the stability and mechanical properties of the ma- 
trix. For example, we have found that the interfacial type I 
collagen in situ is more stable to thermal denaturation (35) 
and more resistant to degradation by vertebrate collagenase 
(11) than is type I elsewhere in the stroma. Likewise, we have 
observed that in regions of thin frozen sections where Desce- 
met's membrane has torn away from the stroma, the fracture 
plane  is  usually  not  at  the  interface between Descemet's 
membrane and the stroma, but just above it (i.e., within the 
stroma itself). The dense interfacial matrix remains tightly 
associated with Descemet's membrane/endothelium as a co- 
hesive unit (unpublished observations). 
During development, the unique array of type IV-contain- 
ing aggregates appears to be derived from a subendothelial 
mat of type IV collagen-containing matrix that arises just af- 
ter a  confluent endothelium is established.  Although it is 
likely that this structure is a product of the endothelium, we 
cannot eliminate the possibility of some contribution from 
adjacent stromal ceils. These appear to secrete type IV colla- 
gen for a limited period during development (unpublished 
results).  The pattern of this type IV collagen-specific im- 
munofluorescence differs from that of conventional base- 
ment membranes in that it is never continuous, appearing in- 
stead as a network of fine strands that may be associated with 
the endothelial surface. As development proceeds, this pat- 
tern gradually assumes the punctate pattern seen in mature 
corneas. This transition correlates temporally with the con- 
tinued production of the nodal matrix of Descemet's mem- 
brane. It seems likely that Descemet's membrane proper is 
deposited between this mat and the endothelium such that fo- 
cal contacts between the mat and the endothelial cells are re- 
tained. These then become more sharply defined as Desce- 
met's membrane increases in thickness.  We do not know 
whether type IV collagen continues to be added to the aggre- 
gates in situ as Descemet's membrane accrues, but it is clear 
that corneal endothelial cells in culture can synthesize type 
IV collagen, along with a variety of  other matrix macromole- 
cules (1, 2, 20, 24, 26, 35, 41). If this reflects the situation 
in situ, the corneal endothelium might prove to be a useful 
model for investigating certain of the mechanisms by which 
matrix macromolecules become deposited in a spatially seg- 
regated manner. 
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